2019
DOI: 10.1007/s00404-019-05248-z
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of ectopic pregnancy with methotrexate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 4 publications
0
1
0
2
Order By: Relevance
“…The current methods for the treatment of cervical pregnancy include systemic medication or local chemotherapeutic debridement. Direct curettage treatment has a high chance of triggering intraoperative hemorrhage and is extremely risky intraoperatively; thus, treating it medically prior to clearance is the key to treatment [ 6 ]. Methotrexate (MTX) chemotherapy has methods of administration such as systemic or ultrasound-guided intrauterine arterial injection, which inhibits trophoblast growth and causes necrosis, shedding, and resorption of embryonic tissue.…”
Section: Introductionmentioning
confidence: 99%
“…The current methods for the treatment of cervical pregnancy include systemic medication or local chemotherapeutic debridement. Direct curettage treatment has a high chance of triggering intraoperative hemorrhage and is extremely risky intraoperatively; thus, treating it medically prior to clearance is the key to treatment [ 6 ]. Methotrexate (MTX) chemotherapy has methods of administration such as systemic or ultrasound-guided intrauterine arterial injection, which inhibits trophoblast growth and causes necrosis, shedding, and resorption of embryonic tissue.…”
Section: Introductionmentioning
confidence: 99%
“…Existen informes de casos de embarazos ectópicos abdominales tempranos tratados exitosamente con metotrexato sistémico sin cirugía adicional (5) . Sin embargo, el tratamiento quirúrgico está indicado cuando existe embarazo ectópico roto, concentraciones séricas de gonadotropina coriónica iguales o superiores a 5,000 UI/L, actividad cardiaca fetal o sospecha de embarazo heterotópico (5,16) .…”
Section: Discussionunclassified
“…Якщо рівень b-субодиниці ХГЛ у сироватці зменшився менше, ніж на 15% на восьму добу, метротрексат вводять повторно у тій же дозі. Якщо рівень b-субодиниці ХГЛ у сироватці збільшився понад 15%, хвору спостерігають, щотижня визначають рівень b-субодиниці ХГЛ до тих пір, поки цей рівень не буде менше 10 МЕ/л [1,4,6,10].…”
Section: результати обговоренняunclassified